Overall survival in a trial of orally administered CCR2 inhibitor CCX872 in locally advanced/metastatic pancreatic cancer: Correlation with blood monocyte counts.
暂无分享,去创建一个
S. Sleijfer | A. Hezel | T. Schall | F. Erdkamp | S. Miao | P. Bekker | D. Linehan | Rajinder Singh | J. Wilmink | F. Eskens | I. Desar | M. Noel | A. Wang-Gillam | Deng Jun | J. Diehl | J. Hillson | A. Potarca | N. Zhao